Table 2.
Treatment assignment ratings for NaHCO3 and placebo during study 2
| After consumption | Pre-TTE cycling | Post-TTE cycling | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SB-SOL | SB-CAP | PL-SOL | PL-CAP | SB-SOL | SB-CAP | PL-SOL | PL-CAP | SB-SOL | SB-CAP | PL-SOL | PL-CAP | |
| Correct ratings | 5 (42%) | 0 (0%) | 6 (50%) | 3 (25%) | 8 (67%) | 3 (25%) | 7 (58%) | 3 (25%) | 9 (75%) | 4 (33%) | 7 (58%) | 4 (33%) |
| Incorrect ratings | 3 (25%) | 1 (8%) | 2 (17%) | 2(17%) | 2 (17%) | 1 (8%) | 1 (8%) | 2 (17%) | 1 (8%) | 2 (17%) | 3 (25%) | 1 (8%) |
| Unsure ratings | 4 (33%) | 11 (92%) | 4 (33%) | 7 (58%) | 2 (17%) | 8 (67%) | 4 (33%) | 7 (58%) | 2 (17%) | 6 (50%) | 2 (17%) | 7 (58%) |
SB-SOL = NaHCO3 in solution; SB-CAP = NaHCO3 in capsules; PL-SOL = placebo in solution; PL-CAP = placebo in capsules. Percentage of treatment assignment ratings displayed in parenthesis. Number of correct guesses that were less than expected by chance alone (< 50%) are highlighted in bold